AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Katz, LM Wang, YF McMahon, B Richelson, E
Citation: Lm. Katz et al., Neurotensin analog NT69L induces rapid and prolonged hypothermia after hypoxic ischemia, ACAD EM MED, 8(12), 2001, pp. 1115-1121

Authors: Richelson, E
Citation: E. Richelson, Pharmacology of antidepressants, MAYO CLIN P, 76(5), 2001, pp. 511-527

Authors: Boules, M Warrington, L Fauq, A McCormick, D Richelson, E
Citation: M. Boules et al., Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats, EUR J PHARM, 428(2), 2001, pp. 227-233

Authors: Boules, M Warrington, L Fauq, A McCormick, D Richelson, E
Citation: M. Boules et al., A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity, EUR J PHARM, 426(1-2), 2001, pp. 73-76

Authors: Boules, M McMahon, B Warrington, L Stewart, J Jackson, J Fauq, A McCormick, D Richelson, E
Citation: M. Boules et al., Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties, BRAIN RES, 919(1), 2001, pp. 1-11

Authors: McMahon, BM Stewart, JA Jackson, J Fauq, A McCormick, DJ Richelson, E
Citation: Bm. Mcmahon et al., Intraperitoneal injection of antisense peptide nucleic acids targeted to the mu receptor decreases response to morphine and receptor protein levels in rat brain, BRAIN RES, 904(2), 2001, pp. 345-349

Authors: Tyler-McMahon, BM Stewart, JA Jackson, J Bitner, MD Fauq, A McCormick, DJ Richelson, E
Citation: Bm. Tyler-mcmahon et al., Altering behavioral responses and dopamine transporter protein with antisense peptide nucleic acids, BIOCH PHARM, 62(7), 2001, pp. 929-932

Authors: Cusack, B Chou, T Jansen, K McCormick, DJ Richelson, E
Citation: B. Cusack et al., Analysis of binding sites and efficacy of a species-specific peptide at rat and human neurotensin receptors, J PEPT RES, 55(1), 2000, pp. 72-80

Authors: Tyler-McMahon, BM Boules, M Richelson, E
Citation: Bm. Tyler-mcmahon et al., Neurotensin: peptide for the next millennium, REGUL PEPT, 93(1-3), 2000, pp. 125-136

Authors: Jansen, K Richelson, E
Citation: K. Jansen et E. Richelson, Detection of peptide nucleic acids in tissue extracts of treated animals by gel mobility shift assay, J BIOCH BIO, 42(1-2), 2000, pp. 31-34

Authors: Richelson, E Souder, T
Citation: E. Richelson et T. Souder, Binding of antipsychotic drugs to human brain receptors - Focus on newer generation compounds, LIFE SCI, 68(1), 2000, pp. 29-39

Authors: Tyler-McMahon, BM Stewart, JA Farinas, F McCormick, DJ Richelson, E
Citation: Bm. Tyler-mcmahon et al., Highly potent neurotensin analog that causes hypothermia and antinociception, EUR J PHARM, 390(1-2), 2000, pp. 107-111

Authors: Boules, M Cusack, B Zhao, LH Fauq, A McCormick, DJ Richelson, E
Citation: M. Boules et al., A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents, BRAIN RES, 865(1), 2000, pp. 35-44

Authors: Cusack, B Boules, M Tyler, BM Fauq, A McCormick, DJ Richelson, E
Citation: B. Cusack et al., Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol, BRAIN RES, 856(1-2), 2000, pp. 48-54

Authors: Richelson, E
Citation: E. Richelson, Society of Biological Psychiatry - Fifty-fifth Annual Convention and Scientific Program - May 11-13, 2000 - Hyatt Regency Hotel Chicago, Illinois - Foreword, BIOL PSYCHI, 47(8), 2000, pp. VI-VI

Authors: Cusack, B Jansen, K McCormick, DJ Chou, T Pang, YP Richelson, E
Citation: B. Cusack et al., A single amino acid of the human and rat neurotensin receptors (subtype 1)determining the pharmacological profile of a species-selective neurotensinagonist, BIOCH PHARM, 60(6), 2000, pp. 793-801

Authors: Richelson, E
Citation: E. Richelson, Receptor pharmacology of neuroleptics: Relation to clinical effects, J CLIN PSY, 60, 1999, pp. 5-14

Authors: Tyler, BM Douglas, CL Fauq, A Pang, YP Stewart, JA Cusack, B McCormick, DJ Richelson, E
Citation: Bm. Tyler et al., In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier, NEUROPHARM, 38(7), 1999, pp. 1027-1034

Authors: Tyler, BM Jansen, K McCormick, DJ Douglas, CL Boules, M Stewart, JA Zhao, LH Lacy, B Cusack, B Fauq, A Richelson, E
Citation: Bm. Tyler et al., Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression, P NAS US, 96(12), 1999, pp. 7053-7058

Authors: Craig, AG Norberg, T Griffin, D Hoeger, C Akhtar, M Schmidt, K Low, W Dykert, J Richelson, E Navarro, V Mazella, J Watkins, M Hillyard, D Imperial, J Cruz, LJ Olivera, BM
Citation: Ag. Craig et al., Contulakin-G, an O-glycosylated invertebrate neurotensin, J BIOL CHEM, 274(20), 1999, pp. 13752-13759

Authors: Tatsumi, M Jansen, K Blakely, RD Richelson, E
Citation: M. Tatsumi et al., Pharmacological profile of neuroleptics at human monoamine transporters, EUR J PHARM, 368(2-3), 1999, pp. 277-283

Authors: Fauq, AH Hong, F Cusack, B Tyler, BM Ping-Pang, Y Richelson, E
Citation: Ah. Fauq et al., Synthesis of (2S)-2-amino-3-(1H-4-indolyl)propanoic acid, a novel tryptophan analog for structural modification of bioactive peptides, TETRAHEDR-A, 9(23), 1998, pp. 4127-4134
Risultati: 1-22 |